This substudy of the large, multicenter RECOVIDS cohort investigated the predictive factors for developing fibrotic changes (FC) in survivors of COVID-19-related Acute Respiratory Distress Syndrome (ARDS) six months after discharge from the Intensive Care Unit (ICU).

Analyzing 440 patients, the researchers found that a significant portion — 36.8% — exhibited fibrotic changes. The study successfully identified several key predictors of this long-term pulmonary complication, which include older age, Body Mass Index (BMI) below 30, a Charlson Comorbidity Index of 1 or greater, the need for invasive mechanical ventilation, early radiological signs of FC, and more extensive lung involvement on baseline CT scans.

The researchers used these factors to develop a predictive nomogram, which demonstrated strong performance with an Area Under the Curve (AUC) of 80.6%.

While late organizing pneumonia was the most frequently observed pattern, a notable subset of patients (18.5% of those with FC) showed anterior fibrosis, suggesting changes related to mechanical ventilation.

These identified predictive factors are crucial, as they can be used to guide personalized therapeutic interventions and follow-up strategies for COVID-19 ARDS survivors, allowing clinicians to more effectively monitor and treat those at highest risk for developing lasting pulmonary fibrosis.

Read More